# Study of Drug Combination on Pharmacokinetics in Healthy Volunteers

> **NCT02175602** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 41 (actual)

## Conditions studied

- Hepatitis C Infection

## Interventions

- **DRUG:** Escitalopram
- **DRUG:** Sertraline
- **DRUG:** DCV 3DAA FDC
- **DRUG:** BMS-791325

## Key facts

- **NCT ID:** NCT02175602
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-08
- **Final completion:** —
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2015-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02175602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02175602, "Study of Drug Combination on Pharmacokinetics in Healthy Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02175602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*